Source link : https://www.newshealth.biz/health-news/no-excess-mace-risk-for-jakis-in-atopic-dermatitis-analysis/
AMSTERDAM — Janus kinase inhibitors (JAKis) do not appear to increase the risk for major adverse cardiovascular events (MACE) among people with atopic dermatitis (AD) treated in a real-world setting, suggested the results of a large, US-based, retrospective cohort study. This holds true even in individuals aged 50 years or older, whose age puts them […]
Author : News Health
Publish date : 2024-10-18 11:13:05
Copyright for syndicated content belongs to the linked Source.
